Table 3.
Comparison of cost of antibiotics
Restricted Antibiotics | Cost (US $) | % difference | |
---|---|---|---|
2001+2002 | 2003+2004 | ||
Meropenem | 9,517,646.80 | 7,156,244.09 | -24.8 |
Imipenem | 3,728,250.96 | 3,389,099.06 | -9.1 |
Ceftazidim | 1,559,280.74 | 989,676.32 | -36.5 |
Ceftriaxone | 7,946,415.82 | 5,024,179.52 | -36.8 |
PIP-TAZO* | 2,310,030.91 | 3,561,111.98 | +54.1 |
Cefepime | 1,918,011.98 | 2,322,463.33 | +21.1 |
Vancomycin | 3,403,176.00 | 2,797,636.80 | -17.8 |
Teicoplanin | 17,328,037.09 | 17,081,283.38 | -1.4 |
Total | 47,710,850.30 | 42,321,694.48 | -11.3 |
*piperacillin-tazobactam